Jul 17, 2026 04:15PM
Jun 17, 2026 04:15PM
Jun 11, 2026 04:15PM
Jun 2, 2026 07:05PM
Jun 2, 2026 07:05PM
May 28, 2026 07:05AM
May 19, 2026 07:05AM Zenas BioPharma to present phase 3 trial results at EULAR 2026
May 19, 2026 07:05AM
May 18, 2026 04:15PM
May 13, 2026 06:50AM
May 13, 2026 06:50AM
May 13, 2026 06:00AM
Apr 17, 2026 04:15PM
Mar 27, 2026 12:13AM Zenas BioPharma prices $300 million dual offering of notes and stock
Mar 27, 2026 12:12AM
Mar 26, 2026 04:01PM
Mar 26, 2026 04:01PM
Mar 16, 2026 06:01PM
Mar 16, 2026 07:00AM
Feb 20, 2026 04:15PM
Feb 9, 2026 07:05AM Zenas BioPharma drug meets primary endpoint in multiple sclerosis trial
Feb 9, 2026 07:05AM
Feb 4, 2026 07:05AM
Jan 16, 2026 04:15PM
Jan 5, 2026 07:05AM
Jan 5, 2026 07:05AM
Dec 19, 2025 04:15PM
Dec 15, 2025 07:05AM InnoCare drug meets primary goal in lupus trial for Zenas partner
Dec 15, 2025 07:05AM
Nov 12, 2025 07:05AM
Nov 11, 2025 07:05AM
Oct 27, 2025 07:05AM
Oct 27, 2025 07:05AM
Oct 8, 2025 05:00AM
Oct 8, 2025 05:00AM Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multip
Sep 2, 2025 07:15AM
Sep 2, 2025 07:15AM
Sep 2, 2025 07:05AM
Aug 26, 2025 07:05AM
Aug 12, 2025 07:05AM
Jun 20, 2025 04:15PM
May 29, 2025 07:05AM Zenas BioPharma to Present at the Jefferies Global Healthcare Conference
May 15, 2025 07:05AM
Apr 17, 2025 04:20PM
Apr 7, 2025 07:06AM
Apr 7, 2025 07:05AM
Mar 17, 2025 07:05AM
Mar 17, 2025 07:05AM
Feb 5, 2025 07:05AM Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases
Jan 28, 2025 08:00AM

1,168,812 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All